Literature DB >> 16198985

Clinical assessment of elderly people with cancer.

Margot A Gosney1.   

Abstract

As the elderly population increases, the diagnosis of cancer will become more common than it is today, and difficult decisions about treatment will need to be made by various health-care providers. An important issue not only for patients but also for the whole health-care system is that only those who will benefit from therapy are treated. Individuals for whom treatment will add neither quantity nor quality to their lifespan should not be subjected to potentially harmful treatment. Many assessment scales are validated in elderly people but not used in elderly patients with cancer. Comprehensive geriatric assessment provides an overarching method of assessment before, during, and after treatment. The benefits and shortcomings of other assessment scales are discussed in this review, showing settings in which their use might be appropriate in the developing specialty of geriatric oncology.

Entities:  

Mesh:

Year:  2005        PMID: 16198985     DOI: 10.1016/S1470-2045(05)70389-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  13 in total

1.  Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.

Authors:  Elisabeth J M Driessen; Judith G M van Loon; Huub A Maas; Anne-Marie C Dingemans; Maryska L G Janssen-Heijnen
Journal:  Lung       Date:  2018-04-12       Impact factor: 2.584

2.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.

Authors:  Barbara Deschler; Gabriele Ihorst; Uwe Platzbecker; Ulrich Germing; Eva März; Marcelo de Figuerido; Kurt Fritzsche; Peter Haas; Helmut R Salih; Aristoteles Giagounidis; Dominik Selleslag; Boris Labar; Theo de Witte; Pierre Wijermans; Michael Lübbert
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 3.  Squamous cell carcinoma of the head and neck in the elderly.

Authors:  Jasenka Gugić; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

4.  Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.

Authors:  Koji Matsuo; Malcolm S Ross; Mayu Yunokawa; Marian S Johnson; Hiroko Machida; Kohei Omatsu; Merieme M Klobocista; Dwight D Im; Shinya Satoh; Tsukasa Baba; Yuji Ikeda; Stephen H Bush; Kosei Hasegawa; Erin A Blake; Munetaka Takekuma; Masako Shida; Masato Nishimura; Sosuke Adachi; Tanja Pejovic; Satoshi Takeuchi; Takuhei Yokoyama; Yutaka Ueda; Keita Iwasaki; Takahito M Miyake; Shiori Yanai; Tadayoshi Nagano; Tadao Takano; Mian Mk Shahzad; Frederick R Ueland; Joseph L Kelley; Lynda D Roman
Journal:  Surg Oncol       Date:  2019-02-07       Impact factor: 3.279

5.  Hypofractionated radiation therapy for treatment of bladder carcinoma in patients aged 90 years and more: A new paradigm to be explored?

Authors:  Benoîte Méry; Alexander T Falk; Avi Assouline; Jane-Chloé Trone; Jean-Baptiste Guy; Romain Rivoirard; Pierre Auberdiac; Julien Langrand Escure; Coralie Moncharmont; Guillaume Moriceau; Hweej Almokhles; Guy de Laroche; Cécile Pacaut; Aline Guillot; Cyrus Chargari; Nicolas Magné
Journal:  Int Urol Nephrol       Date:  2015-05-17       Impact factor: 2.370

6.  Symptom clusters in adults with chronic health problems and cancer as a comorbidity.

Authors:  Catherine M Bender; Sandra J Engberg; Heidi S Donovan; Susan M Cohen; Martin P Houze; Margaret Q Rosenzweig; Gail A Mallory; Jacqueline Dunbar-Jacob; Susan M Sereika
Journal:  Oncol Nurs Forum       Date:  2008-01       Impact factor: 2.172

7.  Modeling individual and relative accuracy of screening tools in geriatric oncology.

Authors:  C A Bellera; F Artaud; M Rainfray; P L Soubeyran; S Mathoulin-Pélissier
Journal:  Ann Oncol       Date:  2017-05-01       Impact factor: 32.976

Review 8.  The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients.

Authors:  Reinhard Stauder
Journal:  Ann Hematol       Date:  2012-05-01       Impact factor: 3.673

9.  The impact of low-grade toxicity in older people with cancer undergoing chemotherapy.

Authors:  T Kalsi; G Babic-Illman; P Fields; S Hughes; N Maisey; P Ross; Y Wang; D Harari
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

10.  Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

Authors:  Pierre Soubeyran; Carine Bellera; Jean Goyard; Damien Heitz; Hervé Curé; Hubert Rousselot; Gilles Albrand; Véronique Servent; Olivier Saint Jean; Isabelle van Praagh; Jean-Emmanuel Kurtz; Stéphane Périn; Jean-Luc Verhaeghe; Catherine Terret; Christophe Desauw; Véronique Girre; Cécile Mertens; Simone Mathoulin-Pélissier; Muriel Rainfray
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.